{
"NDC": {
"NDCCode": "59746-517-07",
"PackageDescription": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59746-517-07)",
"NDC11Code": "59746-0517-07",
"ProductNDC": "59746-517",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Darifenacin",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Darifenacin Hydrobromide",
"DosageFormName": "TABLET, EXTENDED RELEASE",
"RouteName": "ORAL",
"StartMarketingDate": "20161012",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA205550",
"LabelerName": "Jubilant Cadista Pharmaceuticals Inc.",
"SubstanceName": "DARIFENACIN HYDROBROMIDE",
"StrengthNumber": "15",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2017-09-26",
"PackageNdcExcludeFlag": null,
"ProductNdcExcludeFlag": null,
"ListingRecordCertifiedThrough": null,
"StartMarketingDatePackage": null,
"EndMarketingDatePackage": null,
"SamplePackage": null
}
}